MedTrace Logo

Cigarette and E-cigarette Nicotine Content in an Electronic Tobacco Marketplace (ETM)

NCT05320887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2024-10-09

Study results available
· View outcomes & findings →

Summary

This study is proposing a four condition Electronic Tobacco Marketplace (ETM) study to determine if banning normal nicotine content (NNC) is sufficient for encouraging smokers to switch to potentially less harmful products or if the availability of higher nicotine and/or flavored alternative products (specifically e-cigarettes) are needed to achieve maximal reductions in smoking.

Conditions

  • Tobacco Use

Interventions

OTHER

Normal Nicotine Content Vape with all flavor e-liquids

Participants are randomly assigned to the order of each marketplace Group

OTHER

Normal nicotine content vape with tobacco e-liquids

Participants are randomly assigned to the order of each marketplace Group

OTHER

Low nicotine content vape with all flavor e-liquids

Participants are randomly assigned to the order of each marketplace Group

OTHER

Low nicotine content vape with tobacco e-liquids

Participants are randomly assigned to the order of each marketplace Group

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • National Institutes of Health (NIH)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Eric M Donny, PhD · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-27
Primary Completion
2023-07-31
Completion
2023-08-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05320887 on ClinicalTrials.gov